Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients.

about

Sofosbuvir plus ledipasvir for recurrent hepatitis C in liver transplant recipients.

P2860

Q54395595-B8E29968-1F5C-4832-B585-8AAE6E13B841

P2860

Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients.

Item

http://www.wikidata.org/entity/Q36997118

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Sofosbuvir-Based Therapy for G ...... reatment-Experienced Patients.

@en

type

Item

label

Sofosbuvir-Based Therapy for G ...... reatment-Experienced Patients.

@en

prefLabel

Sofosbuvir-Based Therapy for G ...... reatment-Experienced Patients.

@en

P1476

Sofosbuvir-Based Therapy for G ...... reatment-Experienced Patients.

@en

P2093

A Ajlan

http://www.w3.org/2001/XMLSchema#string

A Al-Jedai

http://www.w3.org/2001/XMLSchema#string

D Alkortas

http://www.w3.org/2001/XMLSchema#string

D Broering

http://www.w3.org/2001/XMLSchema#string

F Aba Alkhail

http://www.w3.org/2001/XMLSchema#string

M Al-Sebayel

http://www.w3.org/2001/XMLSchema#string

R Alarieh

http://www.w3.org/2001/XMLSchema#string

W Al-Hamoudi

http://www.w3.org/2001/XMLSchema#string

P2860

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

Sofosbuvir for previously untreated chronic hepatitis C infection

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.

HCV infection among Saudi population: high prevalence of genotype 4 and increased viral clearance rate

Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.

Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial.

The burden of hepatitis C in the United States.

What determines the natural history of recurrent hepatitis C after liver transplantation?

Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?

P304

2872371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/2872371

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

H Elsiesy

P577

2016-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27446833

http://www.w3.org/2001/XMLSchema#string

P921

sofosbuvir

P932

4904700

http://www.w3.org/2001/XMLSchema#string

Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients.

about

P2860

P2860

Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932